2,3-Di-O-para-toluoyl-D-tartaric acid

We are 2,3-Di-O-para-toluoyl-D-tartaric acid CAS:32634-68-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 2,3-Di-O-para-toluoyl-D-tartaric acid
CAS.NO:  32634-68-7
Synonyms:
L-di-p-Toluyltartaric acid
D-DTTA
toluoyl-tartaric acid
Di-4-Toluoyl-D-tartaric acid
Di-p-toluoyl-D-tartaric acid
DI-P-TOTUOYL-D-TARTARIC ACID
Di-p-Toluoyl-D-tartaric
D-PTTA
2,3-Di-O-para-toluoy
(+)-O,O’-Di-p-toluoyl-D-tartaric Acid
(2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid
(+)-O,O′-Di-p-toluoyl-D-tartaric acid
(+)-Di-p-toluoyl-D-tartaric Acid
di-O,O'-p-toluyl-L-tartaric acid
(+)-O,O`-Di-p-toluoyl-D-tartaric Acid

Molecular Formula:C20H18O8
Molecular Weight:  386.35200

Physical and Chemical Properties:
Density: 1.371 g / cm3
Boiling point: 626.5ºC at 760 mmHg
Melting point: 169-171 °C(lit.)
Flash point: 223.2ºC
Refractive index: 1.597

Specification:
Appearance: White or off-white powder or crystilline powder
Purity:≥99.0%
Specific rotation[α]D20（c=1, ethanol）:+136º~ +143º
Clarity: Clear
Water : ≤0.50%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Carumonam Sodium CAS:86832-68-0.

Related News: From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.77451-51-5 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.94610-82-9 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”3,4-Hexanedione “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said.